Effect of ethanol and fructose on liver metabolism: A dynamic 31Phosphorus magnetic resonance spectroscopy study in normal volunteers

Magnetic Resonance Imaging

Volumn 15, Issue 9, 1997, Pages 1067-1077

  Boesch, Chris ^a   Elsing, Christoph ^b   Wegmüller, Herbert ^b   Felblinger, Jacques ^b   Vock, Peter ^b   Reichen, JÜRG ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

Ethanol; Fructose; Liver; Liver function; Magnetic resonance spectroscopy; Phosphorus metabolites

Indexed keywords

ALCOHOL; PHOSPHORUS 31;

ADULT; ALCOHOL METABOLISM; ARTICLE; CONTROLLED STUDY; FRUCTOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; LIVER FUNCTION; LIVER METABOLISM; NORMAL HUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADULT; ANALYSIS OF VARIANCE; ETHANOL; FRUCTOSE; HUMANS; INJECTIONS, INTRAVENOUS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS; REFERENCE VALUES;

EID: 0030773113     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(97)00163-X     Document Type: Article

References (50)

1. 1. Oberhaensli, R.D.; Galloway, G.J.; Taylor, D.J.; Bore, P.J.; Radda, G.K. Assessment of human liver metabolism by phosphorous-31 magnetic resonance spectroscopy. Br. J. Radiol. 59:695-699; 1986.
2. 2. Oberhaensli, R.D.; Hilton-Jones, D.; Bore, P.J.; Hands, L.J.; Rampling, R.P.; Radda, G.K. Biochemical investigation of human tumours in vivo with phosporus-31 magnetic resonance spectroscopy. Lancet 2:8-11; 1986.
3. 3. Terrier, F.; Vock, P.; Cotting, J.; Ladebeck, R.; Reichen, J.; Hentschel, D. Effect of intravenous fructose on the P-31 MR spectrum of the liver - Dose response in healthy volunteers. Radiology 171:557-563; 1989.
4. 4. Dufour, J.F.; Stoupis, C.; Lazeyras, F.; Vock, P.; Terrier, F.; Reichen, J. Alterations in hepatic fructose metabolism in cirrhotic patients demonstrated by dynamic 31phosphorus spectroscopy. Hepatology 15:835-842; 1992.
5. 5. Meyerhoff, D.J.; Boska, M.D.; Thomas, A.M.; Weiner, M.W. Alcoholic liver disease: Quantitative image-guided P-31 MR spectroscopy. Radiology 173:393-400; 1989.
6. 6. Angus, P.W.; Dixon, R.M.; Rajagopalan, B.; Ryley, N.G.; Simpson, K.J.; Peters, T.J.; Jewell, D.P.; Radda, G.K. A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy. Clin. Sci. 78:33-38; 1990.
7. 7. Masson, S.; Desmoulin, F.; Sciaky, M.; Cozzone, P.J. Catabolism of adenine nucleotides and its relation with intracellular phosphorylated metabolite concentration during ethanol oxidation in perfused rat liver. Biochemistry 32:1025-1031; 1993.
8. 8. Buchthal, S.D.; Thoma, W.J.; Taylor, J.S.; Nelson, S.J.; Brown, T.R. In vivo T1 values of phosphorus metabolites in human liver and muscle determined at 1.5 T by chemical shift imaging. NMR Biomed. 2:298-304; 1989.
9. 9. Luyten, P.R.; Bruntink, G.; Sloff, F.M.; Vermeulen, J.W.A.H.; vanderHeijden, J.I.; denHollander, J.A.; Heerschap, A. Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed. 1:177-183; 1989.
10. 10. Argov, Z.; Chance, B. Phosphorus magnetic resonance spectroscopy in nutritional research. Annu. Rev. Nutr. 11: 449-464; 1991.
11. 11. Glazer, G.M.; Smith, S.R.; Chenevert, T.L.; Martin, P.A.; Stevens, A.N.; Edwards, H.T. Image localized 31P magnetic resonance spectroscopy of the human liver. NMR Biomed. 1:184-189; 1989.
12. 12. Rajanayagam, V.; Lee, R.R.; Ackerman, Z.; Bradley, W.G.; Ross, B.D. Quantitative P-31 MR spectroscopy of the liver in alcoholic cirrhosis. J. Magn. Reson. Imaging 2:183-190; 1992.
13. 13. Menon, D.K.; Harris, M.; Sargentoni, J.; Taylor-Robinson, S.D.; Cox, I.J.; Morgan, M.Y. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers. Gastroenterology 108:776-788; 1995.
14. 14. Munakata, T.; Griffiths, R.D.; Martin, P.A.; Jenkins, S.A.; Shields, R.; Edwards, R.H.T. An in vivo 31P MRS study of patients with liver cirrhosis: Progress towards a non-invasive assessment of disease severity. NMR Biomed. 6:168-172; 1993.
15. 15. Meyerhoff, D.J.; Karczmar, G.S.; Matson, G.B.; Boska, M.D.; Weiner, M.W. Non-invasive quantitation of human liver metabolites using image-guided 31P magnetic resonance spectroscopy. NMR Biomed. 3:17-22; 1990.
16. 16. Oberhaensli, R.; Rajagopalan, B.; Galloway, G.J.; Taylor, D.J.; Radda, G.K. Study of human liver disease with P-31 magnetic resonance spectroscopy. Gut 31:463-467; 1990.
17. 17. Seegmiller, J.E.; Dixon, R.M.; Kemp, G.J.; Angus, P.W.; McAlindon, T.E.; Dieppe, P.; Rajagopalan, B.; Radda, G.K. Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. USA. 87:8326-8330; 1990.
18. 18. Oberhaensli, R.D.; Rajagopalan, B.; Taylor, D.J.; Radda, G.K.; Collins, J.E.; Leonard, J.V. Study of liver metabolism in glucose-6-phosphatase deficiency (Glycogen storage disease type 1A) by P-31 magnetic resonance spectroscopy. Pediatr. Res. 23:375-380; 1988.
19. 19. Cunningham, C.C.; Malloy, C.R.; Radda, G.K. Effect of fasting and acute ethanol administration on the energy state of in vivo liver as measured by 31P-NMR spectroscopy. Biochim. Biophys. Acta. 885:12-22; 1986.
20. 20. Helzberg, J.H.; Brown, M.S.; Smith, D.J.; Gore, J.C.; Gordon, E.R. Metabolic state of the rat liver with ethanol: Comparison of in vivo 31 phosphorus nuclear magnetic resonance spectroscopy with freeze clamp assessment. Hepatology 7:83-88; 1987.
21. 21. Cox, I.J.; Coutts, G.A.; Gadian, D.G.; Ghosh, P.; Sargentoni, J.; Young, I.R. Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver. Magn. Reson. Med. 17:53-61; 1991.
22. 22. Twieg, D.B.; Meyerhoff, D.J.; Hubesch, B.; Roth, K.; Sappey-Marinier, D.; Boska, M.D.; Gober, J.R.; Schaefer, S.; Weiner, M.W. Phosphorus-31 magnetic resonance spectroscopy in humans by spectroscopic imaging: Localized spectroscopy and metabolite imaging. Magn. Reson. Med. 12:291-305; 1989.
23. 23. Masson, S.; Henriksen, O.; Stengaard, A.; Thomsen, C.; Quistorff, B. Hepatic metabolism during constant infusion of fructose: Comparative studies with 31P-magnetic resonance spectroscopy in man and rats. Biochim. Biophys. Acta. 1199:166-174; 1994.
24. 24. Cohen, S.M.; Ogawa, S.; Rottenberg, H.; Glynn, P.; Yamane, T.; Brown, T.R.; Shulman, R.G.; Williamson, J.R. 31P nuclear magnetic resonance studies of isolated rat liver cells. Nature 273:554-556; 1978.
25. 25. Salhany J.M.; Stohs, S.J.; Reinke, L.A.; Pieper, G.M.; Hassing. J.M. 31P nuclear magnetic resonance of metabolic changes associated with cyanide intoxication in the perfused rat liver. Biochem. Biophys. Res. Commun. 86: 1077-1083; 1979.
26. 26. McLaughlin, A.C.; Takeda, H.; Chance, B. Rapid ATP assays in perfused mouse liver by 31P NMR. Proc. Natl. Acad. Sci. USA. 76:5445-5449; 1979.
27. 27. Griffiths, J.R.; Stevens, A.N.; Gadian, D.G.; Iles, R.A.; Porteus, R. Hepatic fructose metabolism studied by 31P nuclear magnetic resonance in the anaesthetized rat. Biochem. Soc. Trans. 8:641; 1980.
28. 28. Desmoulin, F.; Canioni, P.; Crotte, C.; Gerolami, A.; Cozzone, P.J. Hepatic metabolism during acute ethanol administration: A phosphorus-31 nuclear magnetic resonance study on the perfused rat liver under normoxic or hypoxic conditions. Hepatology 7:315-323; 1987.
29. 29. Karczmar, G.S.; Kurtz, T.; Tavares, N.J.; Weiner, M.W. Regulation of hepatic inorganic phosphate and ATP in response to fructose loading: An in vivo 31P-NMR study. Biochim. Biophys. Acta. 1012:121-127; 1989.
30. 30. Farghali, H.; Sakr, M.; Gasbarrini, A.; Williams, D.S.; Dowd, S.R.; Ho, C.; Van Thiel, D.H. A biochemical and 31P-NMR investigation of the effect of FK 506 and cyclosporine pretreatment on immobilized hepatocytes perifused with ethanol. Transplant. Proc. 23:2805-2808; 1991.
31. 31. Brauer, M.; Ling, M. The effects of chronic ethanol consumption on the intact rat liver studied by in vivo 31P spectroscopy. Magn. Reson. Med. 20:100-112; 1991.
32. 32. Bates, T.E.; Williams, S.R.; Busza, A.L.; Gadian, D.G.; Proctor, E. A 31P nuclear magnetic resonance study in vivo of metabolic abnormalities in rats with acute liver failure. NMR Biomed. 1:67-73; 1988.
33. 33. Thoma, W.J.; Ugurbil, K. pH and compartimentation of isolated perfused rat liver studied by 31P and 19F NMR. NMR Biomed. 1:95-100; 1988.
34. 34. Lu, W.; Locke, S.J.; Brauer, M. In vivo and in vitro 31P magnetic resonance spectroscopic studies of the hepatic response of healthy rats and rats with acute hepatic damage to fructose loading. Magn. Reson. Med. 31:469-481; 1994.
35. 35. Iles, R.A.; Griffiths, J.R.; Stevens, A.N.; Gadian, D.G.; Porteous, R. Effects of fructose on the energy metabolism and acid-base status of the perfused starved-rat liver. A 31 phosphorus nuclear magnetic resonance study. Biochem. J. 192:191-202; 1980.
36. 36. Koretsky, A.P.; Wang, S.; Murphy-Boesch, J.; Klein, M.P.; James, T.L.; Weiner, M.W. 31P NMR spectroscopy of rat organs, in situ, using chronically implanted radiofrequency coils. Proc. Natl. Acad. Sci. USA. 80:7491-7495; 1983.
37. 37. Roelsgaard, K.; Stodkilde-Jorgensen, H.; Donstrup, S.; Djurhuus, J.C. Non-invasive investigation of parenchymal liver disease using 31P NMR spectroscopy. NMR Biomed. 6:383-388; 1993.
38. 38. Rossaro, L.; Mazzaferro, V.; Scotti-Foglieni, C.L.; Williams, D.S.; Simplaceanu, E.; Simplaceanu, V.; Francavilla, A.; Starzi, T.E.; Ho, C.; Van Thiel, D.H. Effect of cyclosporine on hepatic energy status and on fructose metabolism after portocaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo. Hepatology 13:780-785; 1991.
39. 39. Matthews, J.N.S.; Altman, D.G.; Campbell, M.J.; Royston, P. Analysis of serial measurements in medical research. Br. Med. J. 300:230-235; 1990.
40. 40. Gibaldi, M.; Perrier, D. Pharmacokinetics. In: J. Swarbrick (Ed). Drugs and Pharmaceutical Sciences. Second ed. New York, NY: Marcel Dekker, Inc., 1982: pp. 1-20.
41. 41. Woods, H.F.; Eggleston, L.V.; Krebs, H.A. The cause of hepatic accumulation of fructose 1-phosphate on fructose loading. Biochem. J. 119:501-510; 1970.
42. 42. VanDenBerghe, G.; Bronfman, M.; Vanneste, R.; Hers, H.G. The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase. Biochem. J. 162:601-609; 1977.
43. 43. Brosnan, J.; Chen, L.; Wheeler, C.E.; Van Dyke, T. A.; Koretsky, A.P. Phosphocreatine protects ATP from a fructose load in transgenic mouse liver expressing creatine kinase. Am. J. Physiol. 260:C1191-C1200; 1991.
44. 44. Raivio, K.O.; Kekomaki, M.P.; Maenpaa, P.H. Depletion of liver adenine nucleotides induced by D-fructose. Dose-dependence and specificity of the fructose effect. Biochem. Pharmacol. 18:2615-2624; 1969.
45. 45. Wheeler, T.J.; Lowenstein, J.M. Effects of pyrophosphate, triphosphate, and potassium chloride on adenylate deaminase from rat muscle. Biochemistry. 19:4564-4567; 1980.
46. 46. Wheeler, T.J.; Lowenstein, J.M. Creatine phosphate inhibition of adenylate deaminase is mainly due to pyrophosphate. J. Biol. Chem. 254:1484-1486; 1979.
47. 47. Harris, R.A.; Crabb, D.W. Metabolic interrelationships In: T.M.Devlin (Ed). Textbook of Biochemistry. Third ed. New York, NY: Wiley-Liss. 1992: pp. 575-606.
48. 48. Harris, R.A. Carbohydrate metabolism I: Major metabolic pathways and their control. T.M. Devlin (Ed). Textbook of Biochemistry. Third ed. New York, NY: Wiley-Liss, 1992; pp. 291-358.
49. 49. Krebs, H.A.; Freedland, R.A.; Hems, R.; Stubbs, M. Inhibition of hepatic gluconeogenesis by ethanol. Biochem. J. 112:117-124; 1969.
50. 50. Baranyai, J.M.; Blum, J.J. Quantitative analysis of intermediary metabolism in rat hepatocytes incubated in the presence and absence of ethanol with a substrate mixture including ketoleucine. Biochem. J. 258:121-140; 1989.